AI assistant
Sending…
Cocrystal Pharma, Inc. — Director's Dealing 2021
Jun 2, 2021
35066_dirs_2021-06-02_8b11dd6e-13a6-4ff8-970f-c908ae24845e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2021-05-27
Reporting Person: PFENNIGER RICHARD C JR (Director)
More from Cocrystal Pharma, Inc.
Interim / Quarterly Report
2026
May 15
Regulatory Filings
2026
Apr 23
Regulatory Filings
2026
Apr 2
Annual Report
2026
Mar 31
Regulatory Filings
2026
Mar 31
Director's Dealing
2026
Feb 25
Regulatory Filings
2026
Feb 19
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Jan 15
Director's Dealing
2026
Jan 13